Recent News

By Category: Countermeasures

Improved Nerve Agent Treatment System

The U.S. Department of Defense (DoD) is conducting market research on manufacturing capabilities for the nerve agent antidote scopolamine for intramuscular administration.

Technologies for Host Resilience (THoR)

The Defense Advanced Research Projects Agency (DARPA) has announced a new Technologies for Host Resilience (THoR) Broad Agency Announcement (BAA) to catalyze the development of breakthrough interventions that would increase the ability of patients’ own bodies to tolerate a broad range of pathogens.

VesiculoVax-Vectored Ebola Vaccine Shown Effective and Safe

Results of a study published in today’s issue of the journal Nature demonstrate that a single dose of vaccine administered using Perfectus BioSciences’ VesiculoVax vector platform protects non-human primates against the “Makona” strain of Ebola virus, the strain responsible for the current Ebola outbreak in West Africa.

Biosecurity: DHS Seeks RFID Tracking of Select Agents

The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) Chemical Biological Defense Division is seeking proposals to develop, integrate and implement a standardized Radio Frequency Identification (RFID)-capable, user-friendly, inventory tracking system that ensures the safety of Select Agents within select public health laboratory facilities nationwide.

Smiths Detection Awarded 23M for Chemical Agent Detectors

The U.S. federal government has recently awarded several notable contracts related to the field of chemical, biological, radiological and nuclear (CBRN) countermeasures or life science research of interest for potential applications in biodefense.